Role of short-chain fatty acids in host physiology
- PMID: 38940192
- PMCID: PMC11528394
- DOI: 10.1002/ame2.12464
Role of short-chain fatty acids in host physiology
Abstract
Short-chain fatty acids (SCFAs) are major metabolites produced by the gut microbiota through the fermentation of dietary fiber, and they have garnered significant attention due to their close association with host health. As important mediators between the gut microbiota and the host, SCFAs serve as energy substrates for intestinal epithelial cells and maintain homeostasis in host immune and energy metabolism by influencing host epigenetics, activating G protein-coupled receptors, and inhibiting pathogenic microbial infections. This review provides a comprehensive summary of SCFAs synthesis and metabolism and offering an overview of the latest research progress on their roles in protecting gut health, enhancing energy metabolism, mitigating diseases such as cancer, obesity, and diabetes, modulating the gut-brain axis and gut-lung axis, and promoting bone health.
Keywords: gut microbiota; host; interaction relationship; short‐chain fatty acids.
© 2024 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): An updated review.Crit Rev Food Sci Nutr. 2022;62(22):6034-6054. doi: 10.1080/10408398.2021.1895064. Epub 2021 Mar 11. Crit Rev Food Sci Nutr. 2022. PMID: 33703960 Review.
-
Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.Chem Biol Interact. 2022 Dec 1;368:110231. doi: 10.1016/j.cbi.2022.110231. Epub 2022 Oct 23. Chem Biol Interact. 2022. PMID: 36288778 Review.
-
Gut microbiota-derived short-chain fatty acids and kidney diseases.Drug Des Devel Ther. 2017 Dec 11;11:3531-3542. doi: 10.2147/DDDT.S150825. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 29270002 Free PMC article. Review.
-
Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.J Physiol. 2018 Oct;596(20):4923-4944. doi: 10.1113/JP276431. Epub 2018 Aug 28. J Physiol. 2018. PMID: 30066368 Free PMC article.
-
Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.Int J Mol Sci. 2022 Jan 20;23(3):1105. doi: 10.3390/ijms23031105. Int J Mol Sci. 2022. PMID: 35163038 Free PMC article. Review.
Cited by
-
Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions.Mol Med. 2025 Jan 3;31(1):2. doi: 10.1186/s10020-024-01060-x. Mol Med. 2025. PMID: 39754054 Free PMC article. Review.
-
In vitro fermentation characteristics of polysaccharide from Scrophularia ningpoensis and its effects on type 2 diabetes mellitus gut microbiota.PeerJ. 2025 May 5;13:e19374. doi: 10.7717/peerj.19374. eCollection 2025. PeerJ. 2025. PMID: 40343088 Free PMC article.
-
Multimodal Interventions Targeting Gut Microbiota and Microbial Metabolites in Cognitive Impairment.Cureus. 2025 Jun 10;17(6):e85688. doi: 10.7759/cureus.85688. eCollection 2025 Jun. Cureus. 2025. PMID: 40642664 Free PMC article. Review.
-
Fecal microbiota transplantation from patients into animals to establish human microbiota-associated animal models: a scoping review.J Transl Med. 2025 Jun 17;23(1):662. doi: 10.1186/s12967-025-06645-6. J Transl Med. 2025. PMID: 40528217 Free PMC article.
-
Intestinal-pulmonary axis: a 'Force For Good' against respiratory viral infections.Front Immunol. 2025 Mar 18;16:1534241. doi: 10.3389/fimmu.2025.1534241. eCollection 2025. Front Immunol. 2025. PMID: 40170840 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials